NYSEARCA:BOUT Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News $36.91 -0.32 (-0.87%) As of 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsBuy This Stock About Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BOUT alerts:Sign Up Key Stats Today's Range$36.85▼$37.3250-Day Range$34.94▼$37.9452-Week Range$31.08▼$42.41Volume815 shsAverage Volume2,057 shsMarket Capitalization$11.07 millionAssets Under Management$11.23 millionDividend Yield0.60%Net Expense Ratio0.85%Aggregate RatingModerate Buy ETF Overview The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator. Read More Innovator IBD Breakout Opportunities ETF ExpensesTypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.80%0.47%0.56%0.51%0.53%Other Expenses0.05%0.49%0.56%0.59%0.56%Total Expense0.85%0.67%0.76%0.74%0.73%Fee Waiver0.00%-0.59%-0.66%-0.71%-0.63%Net Expense0.85%0.53%0.63%0.58%0.60% Receive BOUT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BOUT ETF News HeadlinesTop Funds Savor This Breakout Stock. Here's Why.May 28, 2025 | msn.comBreakout Watch: Top Funds Bet On AI-Fueled Fintech Riding 205% GrowthFebruary 19, 2025 | msn.comTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...August 5 at 2:00 AM | InvestorPlace (Ad)Breakout Watch: Some Thought This IPO Was 'Toast' — Then The Tables TurnedFebruary 12, 2025 | msn.comMeta Is Just One Of A Huge Barrage Of Breakouts. Here's The Rest.February 5, 2025 | msn.comTrade War In Focus, But Meta Stock Leads This Swarm Of BreakoutsFebruary 5, 2025 | msn.comSee More Headlines BOUT ETF - Frequently Asked Questions How have BOUT shares performed this year? Innovator IBD Breakout Opportunities ETF's stock was trading at $39.07 at the beginning of 2025. Since then, BOUT shares have decreased by 5.8% and is now trading at $36.81. Who are Innovator IBD Breakout Opportunities ETF's major shareholders? Top institutional investors of Innovator IBD Breakout Opportunities ETF include Comprehensive Money Management Services LLC (9.88%) and Nova Wealth Management Inc. (1.66%). How do I buy shares of Innovator IBD Breakout Opportunities ETF? Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Innovator IBD Breakout Opportunities ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD Breakout Opportunities ETF investors own include NVIDIA (NVDA), ARK Innovation ETF (ARKK), CRISPR Therapeutics (CRSP), Carvana (CVNA), Fastly (FSLY), Luckin Coffee (LKNCY) and Cloudflare (NET). Fund Details IssuerInnovator Capital Management Fund NameInnovator IBD Breakout Opportunities ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BOUT Inception Date9/13/2018 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkIBD Breakout Stocks Index CategoryBroad Equity FocusStrategy Development LevelDeveloped Markets RegionNorth America Number of Holdings139 Fund Statistics Assets Under Management$11.25 million Average Daily Volume$1.67 thousand Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorInnovator Capital Management, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest100 shs Miscellaneous Outstanding Shares300,000Beta0.98 Creation Unit50,000 Creation Fee$250.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report Top 10 BOUT HoldingsResMed (NYSE:RMD)Holding Weight: 3.07%MasTec (NYSE:MTZ)Holding Weight: 2.98%Ferrari N.V.Holding Weight: 2.97%Emerson Electric (NYSE:EMR)Holding Weight: 2.95%Royal Caribbean Cruises (NYSE:RCL)Holding Weight: 2.93%Flutter Entertainment (NYSE:FLUT)Holding Weight: 2.89%CAI International (NYSE:CAI)Holding Weight: 2.88%Microsoft (NASDAQ:MSFT)Holding Weight: 2.88%Charles Schwab (NYSE:SCHW)Holding Weight: 2.88%Amer Sports (NYSE:AS)Holding Weight: 2.84%Full Holdings DetailsBOUT Sector ExposureBOUT Industry Exposure This page (NYSEARCA:BOUT) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD Breakout Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD Breakout Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
